12612 J. Am. Chem. Soc., Vol. 123, No. 50, 2001
Petrache et al.
in human diseases as diverse as cancer, cystic fibrosis, and
multiple sclerosis (see Stillwell12 and Jenski13 for recent
reviews).
cholines, with n ) 12, 14, 16, and 18 carbons, in comparison
with the homologous series of the corresponding symmetric
lipids, di(m:0-d2m-1) phosphatidylcholines. By contrasting the
features of the two homologous series, rather than individual
lipids, one has a qualitative gain in understanding the effect of
polyunsaturation on the bilayer dynamic structure. An alternative
route to investigate the effects of polyunsaturation has been
undertaken by Holte et al.,25,26 who compared lipids with
different levels of unsaturation in the sn-2 position, for a fixed
sn-1 chain (18:0-d35) labeled for 2H NMR spectroscopy. From
this perspective, using a mixed-chain, unsaturated series of
stearoyl phosphatidylcholines, Holte et al.25,26 showed that the
2H NMR spectra of the saturated perdeuterated (18:0-d35) chain
changed markedly with the nature of the sn-2 chain, and
consequently that the order parameter profile changed shape,
with significant perturbation in the midchain region.
One interesting aspect is that the mammalian organism goes
to a long extent to produce and maintain high concentrations
of DHA.14 In particular, mammals must obtain the associated
essential fatty acid precursor 18:3ω3 from their diet in order to
form DHA through a series of enzymatic reactions involving
elongases and desaturases.2 In addition, the susceptibility to
autooxidative damage necessitates large amounts of vitamin E
(R-tocopherol) to prevent degradation of DHA,15 again consis-
tent with an essential biological role of PUFAs.14 However, the
exact mechanisms of action of PUFAs are still largely unknown.
One possibility is that PUFAs act as ligands for receptors
involved in transcription16 or biological signaling.1,17-20 Yet
the large concentration of PUFA-lipids found in the brain and
retina is difficult to explain by such a mechanism. An alterna-
tive hypothesis is that PUFAs yield characteristic membrane
properties associated with lipid-protein interactions.21-23 In
agreement with the second hypothesis, measurements using flash
photolysis have suggested that the bulk properties of DHA-
containing phospholipids are required for proper photoactivity
of the G protein-coupled receptor, rhodopsin.23,24 These proper-
ties may include the elastic curvature stress of the membrane
coupled to the activation of the receptor protein, and subsequent
signal transduction.23 The above observations have led to a
renewed interest in the biophysical properties (structure in
particular) of polyunsaturated bilayers.14,23,25-29 Knowledge of
structural properties enhances our understanding of molecular
level interactions between lipid molecules themselves, as well
as with protein components, because these interactions are
reflected in the intimate molecular packing within the cell
membrane.30-33
In this paper, we follow the approach of Barry et al.34 and
compare bilayers of the polyunsaturated series (n:0-d2n-1)-
(22:6)PC with the disaturated series of di(m:0-d2m-1) phosphati-
dylcholines. Here we focus on the detailed structural properties
of polyunsaturated lipid bilayers in the liquid-crystalline (LR)
state. We have previously investigated35 the homologous series
of disaturated phosphatidylcholines, di(m:0)PC in the LR phase,
and shown how the 2H NMR measurements can be interpreted
using a statistical model for the acyl chain configurational
disorder. The present study represents a natural extension to
the case of mixed-chain, saturated-polyunsaturated bilayers,
in which influences of polyunsaturation on the bilayer physical
2
properties have been systematically explored using H NMR
spectroscopy. By doing so, we discovered a number of interest-
ing new aspects. First, as shown by Salmon et al.30 for the case
of (16:0)(22:6)PC in the fluid state, polyunsaturation at the
glycerol sn-2 position increases the sn-1 chain disorder for all
mixed-chain lipids in the series. This leads to an increased cross-
sectional area (lower surface density) and reduced hydrocarbon
thickness when compared to their disaturated counterparts at a
given absolute temperature. A second important aspect is that,
at fixed absolute temperature, longer sn-1 chains show decreased
order at the chain end (bilayer center) but increased order in
the vicinity of the lipid headgroups. Despite this complex
behavior, we find a universal chain packing curve for the mixed-
chain saturated-polyunsaturated bilayers, just as previously
obtained for the disaturated series.35 By comparing the packing
profiles, we are able to show how the DHA chain affects the
overall chain packing within the bilayer. Finally, the detailed
structural results that emerge from this systematic analysis of
2H NMR data provide a firm conceptual framework for studies
The structural and dynamical properties of polyunsaturated
chains are revealed by comparison with saturated bilayers, as
2
demonstrated by Salmon et al.,30 who contrasted the H NMR
spectrum of (16:0-d31)(22:6)PC with that of di(16:0-d31)PC lipid
bilayers in the fluid (LR) state. The differences in the 2H NMR
spectra were interpreted in terms of an increase in the
configurational freedom of the palmitoyl (16:0) chains due to
2
the adjacent DHA chain. A more extensive H NMR analysis
was performed by Barry et al.34 for the homologous series of
mixed-chain, polyunsaturated (n:0-d2n-1)(22:6) phosphatidyl-
(10) Uauy, R.; Mena, P.; Rojas, C. Proc. Nutr. Soc. 2000, 59, 3-15.
(11) Jorgensen, M. H.; Hernell, O.; Hughes, E. L.; Michaelsen, K. F. J.
Ped. Gastro. Nutr. 2001, 32, 293-296.
(12) Stillwell, W. Curr. Org. Chem. 2000, 4, 1169-1183.
(13) Jenski, L. J. Curr. Org. Chem. 2000, 4, 1185-1200.
(14) Bloom, M.; Linseisen, F.; Lloyd-Smith, J.; Crawford, M. In Magnetic
Resonance and Brain Function: Approaches from Physics; Maraviglia, B.,
Ed.; IOS Press: Amsterdam, 1999; pp 527-553.
(25) Holte, L. L.; Peter, S. A.; Sinnwell, T. M.; Gawrisch, K. Biophys.
J. 1995, 68, 2396-2403.
(26) Holte, L. L.; Separovic, F.; Gawrisch, K. Lipids 1996, 31, S199-
S203.
(27) Litman, B. J.; Mitchell, D. C. Lipids 1996, 31, S193-S197.
(28) Huster, D.; Jin, A. J.; Arnold, K.; Gawrisch, K. Biophys. J. 1997,
73, 855-864.
(29) Huster, D.; Arnold, K.; Gawrisch, K. Biochemistry 1998, 37, 17299-
17308.
(30) Salmon, A.; Dodd, S. W.; Williams, G. D.; Beach, J. M.; Brown,
M. F. J. Am. Chem. Soc. 1987, 109, 2600-2609.
(31) Bloom, M. J.; Evans, E.; Mouritsen, O. G. Q. ReV. Biophys. 1991,
24, 293-397.
(15) Kelley, E. E.; Buettner, G. R.; Burns, C. P. Arch. Biochem. Biophys.
1995, 319, 102-109.
(16) de Urquiza, A. M.; Liu, S. Y.; Sjoberg, M.; Zetterstrom, R. H.;
Griffiths, W.; Sjovall, J.; Perlmann, T. Science 2000, 290, 2140-2144.
(17) Albino, A. P.; Juan, G.; Traganos, F.; Reinhart, L.; Connolli, J.;
Rose, D. P.; Darzynkiewicz, Z. Cancer Res. 2000, 60, 4139-4145.
(18) Chen, Z. Y.; Istfan, N. W. Prostaglandins, Leukotrienes Essent. Fatty
Acids 2000, 63, 301-308.
(19) Siddiqui, R. A.; Jenski, L. J.; Neff, K.; Harvey, K.; Kovacs, R. J.;
Stillwell, W. Biochim. Biophys. Acta 2001, 1499, 265-275.
(20) Kim, H. Y.; Akbar, M.; Lau, A.; Edsall, L. J. Biol. Chem. 2000,
275, 35215-35223.
(32) Petrache, H. I.; Grossfield, A.; MacKenzie, K. R.; Engelman, D.
M.; Woolf, T. B. J. Mol. Biol. 2000, 302, 727-746.
(33) Petrache, H. I.; Zuckerman, D. M.; Sachs, J. N.; Killian, J. A.;
Koeppe, R. E.; Woolf, T. B. Langmuir, in press.
(34) Barry, J. A.; Trouard, T. P.; Salmon, A.; Brown, M. F. Biochemistry
1991, 30, 8386-8394.
(21) Gibson, N. J.; Brown, M. F. Biochem. Biophys. Res. Commun. 1990,
169, 1028-1034.
(22) Mitchell, D. C.; Straume, M.; Litman, B. J. Biochemistry 1992, 31,
662-670.
(23) Brown, M. F. Chem. Phys. Lipids 1994, 74, 159-180.
(24) Liebman, P. A.; Botelho, A. V.; Brown, M. F.; Parkes, J. H. Biophys.
J. 2001, 80, 244.
(35) Petrache, H. I.; Dodd, S. W.; Brown, M. F. Biophys. J. 2000, 79,
3172-3192.